BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc.

NASDAQ:BBIO

Overview | Financials
Company Name BridgeBio Pharma, Inc.
Symbol BBIO
Currency USD
Price 25.2
Market Cap 4,738,431,600
Dividend Yield 0%
52-week-range 21.62 - 44.32
Industry Biotechnology
Sector Healthcare
CEO Dr. Neil Kumar Ph.D.
Website https://www.bridgebio.com

An error occurred while fetching data.

About BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of

Related Stocks

Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc.

ARQT

8.72 USD

Simulations Plus, Inc. logo

Simulations Plus, Inc.

SLP

27.49 USD

Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc.

RXRX

6.64 USD

Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc.

AXSM

87.25 USD

SNDL Inc. logo

SNDL Inc.

SNDL

2.16 USD

LeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc.

LMAT

96.35 USD

Financials

Numbers are in millions USD

Numbers are in millions USD